Kashish Shah

机构：Jacksonville College, WinnMed, Mayo Clinic in Florida

发表论文 9 篇 · 总被引 26 次 · h-index 3

代表论文

• A Review of Anti-CD20 Antibodies in the Management of B-Cell Lymphomas (2024 · Lymphatics · 被引 13)
• Heterogeneity in outcomes of TP53 ‐mutated myeloproliferative neoplasms based on disease phenotype and mutational status (2025 · British Journal of Haematology · 被引 5)
• Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias (2026 · Blood Advances · 被引 4)
• Outcomes of older patients with TP53-mutated myeloid neoplasms (2025 · Blood Cancer Journal · 被引 1)
• Should we treat TP53-mutated high-risk myeloid neoplasms in older patients? (2025 · Journal of Clinical Oncology · 被引 1)
• Incidence of infections, cardiac events, neurological toxicity and cytokine response syndrome (CRS) in patients treated with chimeric antigen receptor (CAR) T cell therapy: A 3-year nationwide analysis. (2025 · Journal of Clinical Oncology · 被引 1)